Connection

DAVID MOORE to CCAAT-Enhancer-Binding Protein-alpha

This is a "connection" page, showing publications DAVID MOORE has written about CCAAT-Enhancer-Binding Protein-alpha.
  1. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology. 2013 Mar; 57(3):1098-106.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.